Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saline versus heparinised saline locks for paediatric oncology central venous access devices
ACTRN12619000393156Phase 3Completed
- Sponsor
- Queensland Children's Hospital
- Start
- Jul 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sodium chloride and heparin in catheter occlusion and Central venous catheter complication (CVCC) (2 arms), sponsored by Queensland Children's Hospital. Primary endpoints: Study feasibility and Occlusive events. Started Jul 2019; status: completed.
02
Drugs
sodium chlorideheparin
03
Conditions
catheter occlusionCentral venous catheter complication (CVCC)
Beyond the preview
Go deeper on ACTRN12619000393156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000393156.